Extended Data Fig. 6: Impact of TAMs on human HR+ breast cancer. | Nature Cancer

Extended Data Fig. 6: Impact of TAMs on human HR+ breast cancer.

From: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2 breast cancer via CX3CR1+ macrophages

Extended Data Fig. 6

a, Mean distance of PD-L1+/PD-L1 macrophages and tumor cells to the nearest γδ T cell in diagnostic biopsies of HR+HER2 BC (n = 26) assessed by multispectral imaging. Box-plots overlaid by individual data points show medians ± interquartile range; whiskers indicate minima and maxima. Relevant and significant (P < 0.05) statistical differences (by two-tailed paired t-test) are shown. Scale bar, 100 μm b, UMAPs for macrophage clusters by scRNAseq, color-coded for the indicated cell type, from longitudinal HR+HER2 BC diagnostic biopsies of responder and non-responder patients receiving preoperative pembrolizumab (α-PD-1) followed by (→) RT plus α-PD-1. Data are pooled from 36 biopsies obtained from 12 patients (3 each: at baseline, after PD-1 and at surgery).

Source data

Back to article page